share_log

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4:持股变动声明-高管 Shah Vinay
美股SEC公告 ·  11/19 05:05

Moomoo AI 已提取核心信息

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah,Adial Pharmaceuticals, Inc.(ADIL)的首席财务官,于2024年11月16日参与了一笔交易。交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格以及交易后的持股情况,在公告中没有披露。作为公司的重要高管,Shah的任何交易活动都受到投资者的密切监控,可能影响市场对该股的看法。
Vinay Shah,Adial Pharmaceuticals, Inc.(ADIL)的首席财务官,于2024年11月16日参与了一笔交易。交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格以及交易后的持股情况,在公告中没有披露。作为公司的重要高管,Shah的任何交易活动都受到投资者的密切监控,可能影响市场对该股的看法。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息